720MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced gynecological cancers (Gynecol C): Results from a phase I studyJian Shu, Qi Zhou, Ruixia Guo et al.|Annals of Oncology|2024Cited by 6
TNIK swaths AR to WNT pathway and drives Castration-Resistant Prostate CancerNing Jiang, Yuanjie Niu, Tao Guo et al.|Research Square (Research Square)|2020Cited by 0